Combination Immune Checkpoint Inhibition: Is First Line Best?

J Clin Oncol. 2023 May 20;41(15):2691-2694. doi: 10.1200/JCO.23.00061. Epub 2023 Feb 28.

Author

Grant A McArthur^{1

2}

Affiliations

¹ Cancer Research Division and Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
² Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.

PMID: 36854080
DOI: 10.1200/JCO.23.00061

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Immune Checkpoint Inhibitors / therapeutic use
Lung Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors